European Antibody Congress

Our mission, for every European Antibody Congress, is to bring you the very best
speakers from big pharma, biotechs, academia and technology innovators to discuss with you the most exciting breakthroughs when it comes to the discovery and development of antibodies.
Whether that’s the newest format of a cancer killing ADC, the most advanced screening technology for mAbs, or the clinical development of a bispecific with promises to treat Alzheimer’s disease, we want to give you access to all of this to grow your knowledge, grow your business, and grow your connections.

Prices:
Standard early bird price (before 31st March) EUR 1930
Academic early bird price (before 31st March) EUR 965

Speakers: Alain Beck, Senior Director, NBEs Analytical Chemistry, Pierre Fabre, Associate Editor, mAbs, Alain Vertes, Managing Director, NxR Biotechnologies, Alexey Rak, Head of Bio Structure and Biophysics, Sanofi R&D, Alfonso Quintas, Head of Clinical Research, Cell Therapies Unit, GSK, André Choulika, CEO, Cellectis, Andrea Gonzalez-Munoz, Research Associate, MedImmune, Andreas Plückthun, Professor of Biochemistry, Director, Department of Biochemistry, University of Zurich, Annelise Vuidepot, VP, Head of Oncology Pipeline and Research, Immunocore, Carsten Kranz, Drug Metabolism and Pharmacokinetics, Novartis Pharma AG, Christian Klein, Head of Oncology Programs, Roche, Christian Rommel, Global Head of Oncology Discovery, Roche, Christoph Merten, Group Leader Microfluidics, European Molecular Biology Laboratory, Christoph Rader, Associate Professor, Department of Immunology and Microbiology, The Scripps Research Institute, Dario Neri, Founder, Philogen; Professor of Chemistry and Applied Biology, Swiss Federal Institute of Technology Zurich, David Brindley, Senior Research Fellow in Healthcare Translation, Department of Paediatrics, University of Oxford, David Gilham, Vice President of Research & Development

Category: Conferences | Science, Health & Medicine | Proteins